You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-HBc alone ；occult HBV infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis b Virus Trial in Bangkok (HBV vaccine)

Completed
  • Hepatitis b Virus
  • HBV vaccine
  • Bangkok, Thailand
    HIV-NAT Thai Red Cross AIDS Research Center
Jul 15, 2020

Dissection of Molecular and Immunological Interaction in HCC of

Not yet recruiting
  • Hepatocellular Carcinoma
    • Tainan, Taiwan
    • +2 more
    Nov 6, 2022

    Hepatitis Flare in Previous Hepatitis B Virus Exposure Amongst

    Terminated
    • Occult Hepatitis B
    • +2 more
      • Hong Kong, Hong Kong
        The Chinese University of Hong Kong
      Jan 14, 2022

      Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)

      Recruiting
      • Hepatitis B Virus Infection
      • Standard antiviral therapy
      • Changsha, Hunan, China
        Department of Infectious Disease, Xiangya Hospital, Central Sout
      May 22, 2022

      Real-world Study Optimizing Nucleotide-analogues

      Recruiting
      • Hepatitis B, Chronic
      • Hefei, Anhui, China
      • +43 more
      Jul 7, 2023

      Hepatitis B Infection, Malignant Solid Tumor Trial in Guam, United States (Best Practice, Entecavir, Tenofovir Alafenamide)

      Recruiting
      • Hepatitis B Infection
      • Malignant Solid Neoplasm
      • Best Practice
      • +3 more
      • Fort Smith, Arkansas
      • +192 more
      Apr 4, 2022

      Disease Loads and Status of Treatment

      Recruiting
      • Chronic Hepatitis B
      • +2 more
      • Prospective serological assays
      • Retrospective serological assays
      • Taipei City, Taiwan
        National Taiwan University Hospital
      Feb 28, 2022

      Access HBV Assays - European Union Clinical Trial Protocol -

      Recruiting
      • HBV
      • Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays
      • Amiens, France
      • +4 more
      Jun 23, 2022

      Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,

      Recruiting
      • Hepatitis B, Chronic
      • ChAd155-hIi-HBV low dose formulation
      • +6 more
      • Antwerpen, Belgium
      • +35 more
      Jan 28, 2022

      HBV, Inflammatory Arthritis Trial (Tenofovir alafenamide)

      Not yet recruiting
      • HBV
      • Inflammatory Arthritis
      • Tenofovir alafenamide
      • (no location specified)
      Aug 5, 2021

      COVID-19 Infection and Its Clinical Prognosis in Chronic

      Recruiting
      • Chronic Hepatitis B
      • COVID-19 Infection
      • Beijing, Beijing, China
        Department of Hepatology Division 2, Beijing Ditan Hospital
      Mar 28, 2023

      HIV, Hepatitis B Trial (Telbivudine, Lamivudine, Efavirenz)

      Withdrawn
      • HIV Infections
      • Hepatitis B
      • (no location specified)
      Oct 28, 2021

      Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

      Recruiting
      • Chronic Hepatitis b
      • test of HBV DNA
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an JiaotongUniversity
      Mar 28, 2022

      Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood

      Not yet recruiting
      • Hepatitis B, Chronic
      • Detection of HBV-DNA in Peripheral Blood Mononuclear cells
      • (no location specified)
      Dec 13, 2021

      Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

      Not yet recruiting
      • Chronic Hepatitis B Virus Infection
      • Kingswood, New South Wales, Australia
      • +28 more
      Jul 21, 2023

      Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

      Active, not recruiting
      • Chronic Hepatitis B
      • Birtinya, Queensland, Australia
      • +21 more
      Dec 20, 2021

      Hepatitis B Reactivations in Patients Affected by Chronic

      Completed
      • Chronic Lymphocytic Leukemia
      • Cona, Ferrara, Italy
      • +22 more
      May 11, 2022

      HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

      Terminated
      • HBe Negative Chronic Hepatitis B
      • Hepatitis B Viral Infection
      • CLEVUDINE + TENOFOVIR PLACEBO
      • +2 more
      • Marseille, France
        Hôpital Saint Joseph
      Jan 30, 2023

      Healthy Volunteer Trial (CampETEC HBC product, ProMilk 85, C. jejuni CG8421 Challenge strain)

      Not yet recruiting
      • Healthy Volunteer
      • CampETEC HBC product
      • +2 more
      • (no location specified)
      Nov 7, 2023

      Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

      Recruiting
      • Chronic HBV Infection
      • Peginterferon alfa-2b combined and ETV
      • Shenzhen, China
        Shenzhen Third People Hospital
      Mar 19, 2023

      HBV Immunity and HBV Vaccination in NAFLD in Canada

      Completed
      Has Results
      • Non-Alcoholic Fatty Liver Disease
      • +2 more
      • Engerix-B
      • Calgary, Alberta, Canada
        University of Calgary
      Nov 2, 2021

      Hepatitis B Infection Trial in Dhaka (Hepa-B, Engerix B)

      Completed
      • Hepatitis B Infection
      • Hepa-B
      • Engerix B
      • Dhaka, Mirpur, Bangladesh
        Mirpur Field Office
      Feb 10, 2022

      Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

      Enrolling by invitation
      • Chronic Hepatitis B
      • Non-alcoholic Fatty Liver Disease
      • exercise
      • Taipei, Zhongzheng Dist., Taiwan
        National Taiwan University Hospital
      Jul 13, 2023

      IBD, Hepatitis B Trial in Hong Kong (Intradermal hepatitis B vaccine with imiquimod, Intramuscular hepatitis B vaccine with

      Completed
      • Inflammatory Bowel Diseases
      • Hepatitis B
      • Intradermal hepatitis B vaccine with imiquimod
      • Intramuscular hepatitis B vaccine with aqueous cream
      • Hong Kong, China
        Queen Mary Hospital
      May 17, 2022

      Towards a Functional Cure for HBV - The COMMIT Cohort Study

      Active, not recruiting
      • Hiv
      • HBV Coinfection
        • Chennai, India
        • +2 more
        May 30, 2022